Heart defect prediction technology could lead to earlier, more informed treatment

An experimental model uses genetics-guided biomechanics and patient-derived stem cells to predict what type of inherited heart defect a child will develop, according to authors of a new study. A multi-institutional team developing the technology announces that it would let doctors intervene earlier to help patients manage their conditions and help inform future pharmacologic treatment options.